News
2d
Stocktwits on MSNSunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge InRetail chatter around Sunshine Biopharma surged late Wednesday after the company introduced Niopeg, its first biosimilar drug ...
Centene withdrew its previous 2025 earnings guidance and all underlying guidance elements based on the company's preliminary ...
Clinical Data Studio has supported 465 global studies since its launch in 2024, reducing data review cycles by up to 80% and ...
Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move ...
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; 'Cyclacel” or the 'Company”), a biopharmaceutical company ...
Investing.com -- Vor Biopharma Inc (NASDAQ: VOR) stock surged 85% after the company announced an exclusive licensing agreement with China’s RemeGen Co., Ltd. for telitacicept, a novel dual-target ...
Bristol-Myers Squibb Company (NYSE:BMY) is the third biopharmaceutical company on the list of the 10 undervalued blue chip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results